IDENTIFICATION AND CLASSIFICATION OF SEROSAL INVASION, AS IT RELATES TO CANCER CELL SHEDDING AND SURGICAL-TREATMENT IN GASTRIC-CANCER

被引:10
作者
CHEN, JQ
LIU, QH
机构
[1] Cancer Institute, China Medical University, Shenyang
来源
SEMINARS IN SURGICAL ONCOLOGY | 1994年 / 10卷 / 02期
关键词
GASTRIC CANCER; SEROSA; SHEDDING; SURGERY;
D O I
10.1002/ssu.2980100208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgery to the extent of R+1 [gastric resection plus removal of group 1 lymph nodes (N1) and part of group 2 lymph nodes (N2)] is adequate for cancer confined to the mucosa when the serosa is normal, while operation at the R2 level is adequate for cancer confined to the submucosa (SM) or the muscularis propria (PM) when the serosa is of the reactive type. As the status of serosal involvement advances from normal to reactive, nodular, tendonoid and colour diffused, the lymph node metastatic rate soars and the 5-year survival rate declines in that order. There were no peritoneally shed cancer cells in cases with normal or reactive serosa over the lesion. Shed cancer cells increased significantly when the serosal involvement exceeded 30 cm2. The 2-year survival rate of the patients who had serosal involvement increased by 23.1% when peritoneal lavage with 43-degrees-C distilled water was done. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 8 条
[1]  
Chen J, Qi C, Shan J, Serosa typing in gastric cancer and its significance, Natl Med J China, 66, pp. 736-738, (1986)
[2]  
Liu Q, Chen J, The relationship between serosal types, pathological characteristics and free cancer cells in the peritoneal cavity of gastric cancer patients, J Chin Cancer Res, 1, 3, pp. 58-61, (1989)
[3]  
Chen J, Zhang Z, Guong W, The killing effect of hypo‐osmolar solution and hyperthemia on gastric cancer cells MGC‐803, Chin J Oncol, 13, pp. 97-99, (1991)
[4]  
Nishi M, Nakajima T, Prognostic factors of gastric cancer, JPN J Cancer Chemother, 15, pp. 2186-2193, (1988)
[5]  
Zhang W, Sun Z, Prognosis of gastric cancer, Gastric Cancer, (1987)
[6]  
Koga S, Hamazoe R, Maeta M, Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with MMC, Cancer, 61, pp. 232-237, (1988)
[7]  
Baba T, Some recent developments in cancer chemotherapy, Jpn J Soc Clin Surg, 49, pp. 209-213, (1988)
[8]  
Fujimoto S, Shrestha R, Kokubun M, Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding, Ann Surg, 208, pp. 36-41, (1988)